Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Tubular”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Post-approval studies (Phase 4)Study completedNCT00844675
What this trial is testing

Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection

Who this might be right for
Early Gastric AdenocarcinomaAdenocarcinoma, Tubular
The Catholic University of Korea 120
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Not applicableStudy completedNCT00945061
What this trial is testing

Radiation Therapy in Treating Patients With Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 13
Very early researchStudy completedNCT00527293
What this trial is testing

Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 29
Not applicableStudy completedNCT06599749
What this trial is testing

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)

Who this might be right for
Adenocarcinoma of OvaryAdenocarcinoma, TubularPeritoneal Cancer
University Hospital, Basel, Switzerland 80
Testing effectiveness (Phase 2)Study completedNCT00002873
What this trial is testing

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)WithdrawnNCT01100489
What this trial is testing

Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast Cancer+13 more
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT02125344
What this trial is testing

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Who this might be right for
Tubular Breast Cancer Stage IITubular Breast Cancer Stage IIIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 961
Testing effectiveness (Phase 2)Study completedNCT01417286
What this trial is testing

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

Who this might be right for
Inflammatory Breast CancerInvasive Ductal Breast CarcinomaInvasive Lobular Breast Carcinoma+7 more
Rutgers, The State University of New Jersey 69
Not applicableNot Yet RecruitingNCT07260461
What this trial is testing

The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer.

Who this might be right for
Stomach NeoplasmsAdenocarcinoma - Gastroesophageal Junction (GEJ)Gastroesophageal Junction Cancer
First Affiliated Hospital of Wenzhou Medical University 120
Testing effectiveness (Phase 2)Study completedNCT01082211
What this trial is testing

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 65
Testing effectiveness (Phase 2)Study completedNCT02682693
What this trial is testing

Denosumab as an add-on Neoadjuvant Treatment (GeparX)

Who this might be right for
Breast Cancer Female NOSTubular Breast Cancer Stage IIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 780
Large-scale testing (Phase 3)Study completedNCT01426880
What this trial is testing

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 595
Not applicableStudy completedNCT00599989
What this trial is testing

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerLong-term Effects Secondary to Cancer Therapy in AdultsSkin Reactions Secondary to Radiation Therapy
Abramson Cancer Center at Penn Medicine 28
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Large-scale testing (Phase 3)Active Not RecruitingNCT02221999
What this trial is testing

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 250
Early research (Phase 1)Study completedNCT00749437
What this trial is testing

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
University of Medicine and Dentistry of New Jersey 34
Not applicableStudy completedNCT02186470
What this trial is testing

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma With Predominant Intraductal Component+7 more
Ohio State University Comprehensive Cancer Center 22
Next Page